Vivos Therapeutics, Inc. (VVOS) Financials
VVOS Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 24.1 million | 28.1 million |
| March 31, 2026 | 25.0 million | 26.3 million |
| Dec. 31, 2025 | 25.2 million | 26.7 million |
| Sept. 30, 2025 | 25.6 million | 23.1 million |
VVOS Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | -3.1 million | 50000 |
| March 31, 2026 | -6.0 million | 151000 |
| Dec. 31, 2025 | -4.7 million | 47000 |
| Sept. 30, 2025 | -4.1 million | 55000 |
VVOS Net Income
No data available :(
VVOS Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 1.8 million | 3.5 million | - |
| March 31, 2026 | 2.1 million | 418000 | 4.6 million |
| Dec. 31, 2025 | 2.0 million | 469000 | 4.7 million |
| Sept. 30, 2025 | 3.1 million | 8.4 million | 3.8 million |
VVOS Shares Outstanding
VVOS Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 18000 | - | 7.3 million | 155000 |
| March 31, 2026 | 18000 | - | 9.2 million | 249000 |
| Dec. 31, 2025 | 893000 | - | 8.9 million | 382000 |
| Sept. 30, 2025 | 83000 | - | 8.3 million | 403000 |
VVOS Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | 5.2 million | 2.2 million |
| March 31, 2026 | 5.1 million | 2.5 million |
| Dec. 31, 2025 | 3.8 million | 836000 |
| Sept. 30, 2025 | 6.8 million | 2.8 million |
VVOS Revenue by Segment
Graph available only for paid members. Upgrade to see it.
VVOS
Price: $0.18
52 week price:
Earnings Per Share: -1.88 USD
Exchange: NCM
Sector: Healthcare
Industry: Medical Devices
Country: United States
Volume: 77800
Market Capitalization: 2.6 million